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Abstract
Background: RNA sequencing has opened new avenues for the study of transcriptome composition. Significant
evidence has accumulated showing that the human transcriptome contains in excess of a hundred thousand
different transcripts. However, it is still not clear to what extent this diversity prevails when considering the relative
abundances of different transcripts from the same gene.
Results: Here we show that, in a given condition, most protein coding genes have one major transcript expressed
at significantly higher level than others, that in human tissues the major transcripts contribute almost 85 percent to
the total mRNA from protein coding loci, and that often the same major transcript is expressed in many tissues.
We detect a high degree of overlap between the set of major transcripts and a recently published set of
alternatively spliced transcripts that are predicted to be translated utilizing proteomic data. Thus, we hypothesize
that although some minor transcripts may play a functional role, the major ones are likely to be the main
contributors to the proteome. However, we still detect a non-negligible fraction of protein coding genes for which
the major transcript does not code a protein.
Conclusions: Overall, our findings suggest that the transcriptome from protein coding loci is dominated by one
transcript per gene and that not all the transcripts that contribute to transcriptome diversity are equally likely to
contribute to protein diversity. This observation can help to prioritize candidate targets in proteomics research and
to predict the functional impact of the detected changes in variation studies.
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Background
Although there are fewer than 22,000 protein coding
genes known in the human genome, they are transcribed
into over 140,000 different transcripts (Ensembl release
66 [1]), over 65% of which have protein coding potential
and thus may contribute to protein diversity. Recently,
applications of high throughput sequencing to RNA,
known as RNA-seq [2], have opened new avenues for the
study of transcriptome composition [3]. RNA-seq is
based on sequencing short fragments, thus making the
precise reconstruction of full-length transcripts a difficult
task; nevertheless, several methods have been developed
to deconvolute transcript abundance [4-6]. Significant
evidence has accumulated showing that approximately
95% of multiexon genes have more than one alternative
splice-form expressed (for example, [4,7-9]) and that
transcript expression is regulated [10,11]. On the other
hand, focusing on EST data, Taneri et al. [12] predicted
that there is a single dominant transcript per gene in pri-
mary tissues. Recently, the ENCODE project [13] showed
that indeed, in cell lines most genes have a major tran-
script, although at the same time noted that ‘genes tend
to express many transcripts simultaneously, and as the
number of annotated transcripts per gene grows, so does
the number of expressed transcripts’. However, despite
these observations, it is still not clear if and to what
extent major transcripts are dominating the transcrip-
tome and what proportion of the transcript diversity is
likely to contribute to protein diversity. In addition, given
the notable differences in gene expression between pri-
mary tissues and cell lines [11,14], transcriptome analysis
in cell lines can be extended to primary tissues only to
some extent.
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Here we intend to characterise the potentially coding
transcriptome from a functional perspective. By focusing
on protein coding genes, we show that in primary tissues
almost 85% of the total mRNA from protein coding loci
comes from major transcripts (76% in cell lines). It is
important to highlight that these major transcripts are not
always the longest possible for the gene (40% of the major
transcripts in primary tissues and 30% in cell lines are not
the longest annotated), nor always include the longest
CDS (Coding DNA Sequence; approximately 50% of the
cases in both tissues and cell lines). For instance, we iden-
tified the AES gene (amino-terminal enhancer of split), for
which we detect a ubiquitous major transcript that is
shorter than the current reference. We also show that the
ratio of the number of expressed transcripts to genes
in primary tissues is on average 1.12 (that is, just over
one transcript per gene). We further distinguish between:
(1) major transcripts - the transcript with the highest
expression level within a given gene; and (2) dominant
transcripts - a major transcript that is expressed at a con-
siderably higher level than any minor transcripts of the
gene. We show that most protein coding genes in most
conditions have one dominant transcript, for example, for
almost 80% of the expressed genes in primary tissues
the major transcript is at least twice as abundant as the
next one.
We further observe that about half of the ubiquitously
expressed genes (n = 4,801) have the same major tran-
script across all the 16 tissues studied here. We do, how-
ever, detect switch events for approximately 35% of the
genes, where the dominant and minor transcripts switch
between different tissues, while the total expression level
of the gene changes comparatively little. In around 100
genes we observe such a strong change that we can
hypothesise that the different transcripts are likely to be
translated into different proteins. One example is the MBP
gene (Myelin Basic Protein), which is a major protein con-
stituent of the myelin sheath. A shorter brain specific form
has been detected by this analysis and has been high-
lighted recently in the literature [15]. Finally, we observe
that for almost 20% of the studied protein coding genes
(n = 18,450) the major transcript does not code for a pro-
tein, and this percentage is considerably higher in nucleus
than in cytosol. Half of the noncoding major transcripts
can be explained by a retained intron, typically located
towards the 3’-end of the transcript.
We perform the analyses using three different computa-
tional methods [4-6], and additionally, where sufficient
coverage exists, we assess the alternative transcript abun-
dances directly from the reads spanning unique exon junc-
tions. We also use simulated data [16] to confirm that the
methods can reliably distinguish between two hypothetical
alternative scenarios - one dominant transcript per gene
vs. several transcripts per gene expressed to similar levels.
All those methods produce a consistent outcome, indicat-
ing robustness of the conclusions presented here.
Overall, our results show that, despite of the diversity
of the transcriptome, most protein coding genes have
one dominant transcript, which, when combined, com-
prise most of the potentially coding mRNA transcrip-
tome. Correlation between transcriptome and proteome
is not straightforward, with the best estimates pointing
at a range of 58% to 63% correlation [17]. However, the
strong overlap with a set of isoforms that are indepen-
dently predicted to be translated into proteins, together
with the clear separation in expression levels between
major and minor transcripts, add support to the hypoth-
esis that the dominant transcripts are likely to be the
main contributors to the proteome. Thus, our findings
may help proteome analysis by prioritising the candidate
proteins that are more likely to be present in a given
sample. At the same time, identification of changes in
the major transcript across conditions can lead to rele-
vant clinical findings (for example, [18]) and may also
be used to predict the functional impact of the detected
changes in variation studies. Nevertheless, this does not
imply that all minor transcripts do not have a biological
function, since some may still be translated into proteins
[19] or have a regulatory function as mRNAs [20].
Results and discussion
Here we quantify and analyse the overall contribution of
major transcripts to the potentially coding mRNA tran-
scriptome, in comparison to minor transcripts. The datasets
analysed comprise 16 primary human tissues - Illumina
Body Map dataset (BM), further referred to as tissue data -
and 5 ENCODE cell lines, including different cellular com-
partments (whole cell, cytosol and nucleus) - further
referred to as cell line data (see Methods).
Most protein coding genes express one dominant
transcript
First, examining only the tissue data, and similarly to pre-
vious RNA-seq-based transcriptome studies, we detect
more than one transcript for approximately 85% of the
studied genes (83.70% to 89.95%, SD = 1.84, Additional
File 2 - Table S1) and a total of 105,456 different tran-
scripts in at least one tissue, which corresponds to
approximately 90% of the studied transcripts (n =
117,759; see Methods). However, when quantifying all
the annotated transcripts within a gene based on their
relative abundance, we observe the existence of a predo-
minant transcript for most genes in most conditions,
rather than a subset of transcripts that are similarly
expressed (Figure 1a, Additional File 1 - Figure S1 and
Additional File 1 - Figure S2). This observation becomes
even more evident when grouping transcripts by Tran-
scription Start Site (TSS), which provides a scenario
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where all the different transcripts are under similar tran-
scriptional control and where most differences in their
abundance can be attributed to alternative splicing (AS;
Additional File 1 - Figure S4). In the same line, we
observe that the ratio of the number of expressed tran-
scripts to genes in primary tissues is 1.12 (0.98-1.40, SD
= 0.11; Additional File 2 - Table S2). Finally, we find that
in the studied samples approximately 85% (79.98% to
86.49%, SD = 2.17) of the mRNA pool from protein cod-
ing loci is comprised exclusively of major transcripts
(Figure 1b and Additional File 2 - Table S3). In order to
address the impact of our observations at the protein
level, we plotted the distribution of expression levels for
both major and minor transcripts (Figure 1c) and
observed that minor transcripts tend to be expressed
below 1 FPKM, a threshold that has been suggested as
the minimum expression required for protein detection
[21-23]. In addition, we calculated the overlap of our
major/minor transcript predictions with those obtained
from an independent study to assess which transcripts
are likely to be translated into proteins and detected a
higher overlap for major transcripts (see Additional File 4
- Supplementary Results).
We quantified transcript dominance by calculating for
every gene the ratio of the expression levels between the
major transcript and the second most abundant one
(Additional File 1 - Figure S4). Overall, we found that in
the studied tissues, 79% of the genes (74.21% to 81.94%,
SD = 2.16) have a two-fold dominant major transcript
(that is, expressed twice as much as the second most
abundant one), and that for 56% of the genes (43.39% to
61.60%, SD = 3.50) the major transcript is five-fold domi-
nant (Table 1 and Additional File 2 - Table S4). This indi-
cates that for most genes in a given sample there is one
dominant transcript. We estimate that dominant transcripts
account for most of the studied mRNA pool - 76.69%
(70.04% to 80.74%, SD = 3.48) for a two-fold dominance
and 67.47% (59.97% to 73.83%, SD = 4.81) for a five-fold
dominance (Figure 1b). GO enrichment analysis of genes
that consistently express a five-fold dominant transcript
across the 16 tissues in the tissue dataset indicated that
they are functionally involved in cellular respiration, protein
transport, transcription and transcription regulation (Addi-
tional File 2 - Table S5). We also calculated the fraction of
dominant major transcripts vs. non-dominant ones for dif-
ferent FPKM thresholds on total gene expression. The pro-
portion of dominant major transcripts increases with
Figure 1 Most protein coding genes express one predominant transcript. (a) Relative abundance of the subset of transcripts in each
position of the ranking for the primary tissues dataset. For each gene, transcripts were ranked based on their relative abundances. There is
generally one predominant transcript over the rest. (b) Percentage of the studied mRNA pool explained by each category of transcripts for the BM
dataset. The mean percentage for all samples is represented here. Major transcripts represent approximately 85% of the studied mRNA population and
were further classified into two-fold and five-fold dominant. (c) Expression distribution for major and minor transcripts in the tissue dataset. We
detect a total of 31,902 transcripts expressed above 1 FPKM in at least one tissue and 26,641 different major transcripts.










1 FPKM 10,410 56.42% 8,179 78.51% 5,864 56.22%
5 FPKM 4,671 25.32% 3,898 83.64% 3,077 66.27%
10 FPKM 2,486 13.47% 2,146 86.54% 1,794 72.60%
Average number of genes with dominant major transcripts detected in the
primary tissues dataset. Different dominance ratios and gene expression
thresholds were considered in the quantification.
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higher FPKM thresholds, thus suggesting that transcrip-
tome diversity decreases for highly expressed genes (Addi-
tional File 1 - Figure S5). Focusing on genes that tend to
express several transcripts at a similar level, we identified
463 genes in the tissue dataset for which the major tran-
script was less than five-fold dominant in all the tissues
analysed, and only 17 for a two-fold dominance threshold.
GO enrichment analysis of those revealed that they are
involved in RNA splicing/processing, post-transcriptional
regulation of gene expression and regulation of translation
(Additional File 2 - Table S6).
We applied the same quantifications in cell line data,
including different cellular compartments, and observed
that major transcripts constitute approximately 80% of the
studied mRNA pool in cytosol (77.20% to 83.66%, SD =
1.98, Additional File 2 - Table S3). Overall, transcript dom-
inance was less accentuated than in primary tissues - 69%
(63.11% to 71.17%, SD = 2.40) of genes with a two-fold
dominant major transcript and 42% (35.16% to 44.76%, SD
= 2.90) with a five-fold dominant transcript in cytosol
(Additional File 2 - Table S4). These differences could
reflect higher transcription and splicing rates in cell lines,
although they could also be due to technical variability
between the two datasets.
Given that estimating transcript expression from short
reads is a challenging task, we performed additional ana-
lyses to test the reliability of our observations. First, we
simulated different RNA-seq datasets to test whether the
method used can distinguish between two hypothesised
scenarios - one dominant transcript per gene vs. similar
expression levels of the different transcripts in each gene
(see Methods) - and concluded that our method reliably
discriminates between those, even when taking into
account different sequencing depths (Additional File 1 -
Figure S6). In addition, this analysis reveals that the
method is not biased towards the identification of a single
transcript per gene (see Additional File 1 - Figure S6) and
reproduces our previous findings about transcript domi-
nance (Additional File 2 - Table S7). Second, we used
alternative methods to estimate transcript expression
levels and identify major transcripts, including direct evi-
dence from junction reads. All the methods have a strong
overlap in the predictions (see Additional File 2 - Table S8
and Methods). Third, we analysed the length distribution
of major transcripts to determine whether the identifica-
tion of major transcripts is biased towards the longest one
for each gene. We observe that the length of the major
transcript is distributed widely (Additional File 1 - Figure
S7) and that in >50% of the cases (50.98% to 55.46%, SD =
1.53) the major transcript is not the longest one annotated
(Additional File 2 - Table S9 and Additional File 3 - File
S1). The same trend is observed when taking into account
CDS length: we estimate that in approximately 50% of the
cases (44.42% to 48.23%, SD = 1.12) the major transcript
does not contain the longest CDS, thus not corresponding
to the ‘canonical’ transcript as annotated in UniProt (Addi-
tional File 2 - Table S9 and Additional File 3 - File S1). For
instance, we identified the AES (amino-terminal enhancer
of split) and CD47 (CD47 molecule) genes, for which we
detect a ubiquitous major transcript that is shorter than
the current reference (Figure 2 and Additional File 1 -
Figure S8). Finally, we addressed the impact of unnano-
tated transcripts in our observations by performing de novo
transcript identification using Cufflinks (see Methods). As
expected, we observe a higher number of transcripts per
gene (6.38 in GENCODE v11 vs. 12.84 using Cufflinks),
although the main message still prevails (Additional File 1
- Figure S9 and Additional File 2 - Table S10).
Major transcripts tend to be recurrent across samples
We next sought to quantify how often we detect the same
major transcript across different samples. Focusing on the
tissue dataset, and taking into account genes that are
expressed in at least two different tissues, we estimate that
this is the case for 35% of the genes (Figure 3a and Addi-
tional File 3 - File S2); while approximately 50% of the
genes that are ubiquitously expressed (that is, expressed in
all the 16 tissues) have the same major transcript (Figure
3a). For higher expression thresholds the overlap in the
major transcript increases to 79% (Additional File 2 -
Table S11). In addition, comparison of expression patterns
for major and minor transcripts revealed that the former
tend to be expressed in a recurrent fashion (Additional
File 1 - Figure S10). In the cell line dataset, we detected
similar major transcript expression patterns, with substan-
tial differences depending on the subcellular fraction
analysed (see Additional File 4 - Supplementary Results).
On the other hand, we still detect a significant fraction
of genes (>60%) for which the identity of major transcripts
changes across conditions. To quantify these differences,
we study switch events - changes of dominant transcripts
between samples. We define a gene to undergo a two-fold
(or five-fold) switch between two samples, if this gene has
two different two-fold (or five-fold) dominant transcripts
in the respective samples, while the overall expression of
the gene does not change abruptly between the two sam-
ples (see Figure 3b and Methods). From the pairwise com-
parison of the 16 tissues, we found that approximately
35% of the studied genes (n = 14,626) are involved in two-
fold switch events, and approximately 10% in five-fold
switch events. However if we additionally require the
dominant transcripts to be expressed over 5 FPKM and
the minor ones under 1 FPKM, thus increasing the chance
that the switch might have an effect at the protein
level, the number of such strong switches drops to <1%
(Figure 3a, Additional File 2 - Table S12 and Additional
File 3 - File S4). Further focusing on strong switch events
across tissues, we detected only 67 genes for which the
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Figure 2 Example of non-canonical major transcript common to all the 16 tissues analysed: AES (amino-terminal enhancer of split,
ENSG00000104964). Read coverage for the gene (a) and screenshot from the Zmap manual annotation interface (b). UTR exons and splice
variants with no annotated CDS are shown in red, coding exons are shown in green and the CDS portion of models annotated as NMD are
shown in purple. Clusters containing >8,000 CAGE tags defining transcription start suites are shown as small blue boxes, CpG islands are shown
as yellow boxes broken by horizontal red bars representing TSS predictions from EPONINE [59]. The short horizontal green bars represent
polyadenylation sites identified by polyAseq [60].
Figure 3 Expression patterns for major transcripts. (a) Percentage of genes with recurrent and non-recurrent major transcripts. Changes in the
identity of major transcripts across samples were quantified with switch events. (b) Concept of switch event. A gene is considered to be involved
in a switch event if we detect two different dominant major transcripts in two different samples. If the dominant transcripts involved in the
switch are expressed above 5 FPKM, while the minor ones are expressed below 1 FPKM, we define the event as a strong switch.
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switch implied a change in the protein sequence. Tran-
script expression profiles for this last subset of events can
be visualised in Additional File 1 - Figure S11. One exam-
ple is the MBP gene (Myelin Basic Protein), for which we
detect a brain specific major transcript (Figure 4 and Addi-
tional File 1 - Figure S12).
As our tissue dataset lacks biological replicates, we
cannot distinguish which of the switch events are tissue
specific, as opposed to individual specific or due to tech-
nical or biological noise. Reassuringly, we observed that
genes with high variability in splicing across tissues are
enriched for transit peptides, among other GO terms
(Additional File 2 - Table S13 and Methods), thus sug-
gesting that biological variability dominates above tech-
nical variability. In addition, in order to estimate to
what extent technical variability could influence our
estimates, we repeated the same analyses in the cell line
dataset, where we observed that the number of switch
events detected across cell lines is significantly higher
than the one detected across replicates (that is, 10 times
higher for five-fold switch events, Additional File 1 -
Figure S13). Overall, the proportion of switch events
detected in the cell line data is lower than the one
observed in the tissue data (Additional File 2 - Table
S12 and Additional File 3 - File S5).
Major transcripts do not always code for proteins
Functional classification of major transcripts revealed that
for 17% (15.26% to 20.64%, SD = 1.60) of protein coding
genes expressed in primary tissues the major transcript
lacks an annotated CDS as indicated by GENCODE (see
Additional File 4 - Supplementary Methods). Taking into
account expression levels, and focusing on cell line data,
we observe that major non-coding transcripts are more
abundant in the nucleus, where they represent approxi-
mately 15% of the studied mRNA pool (12.99% to 16.66%,
SD = 1.10, Figure 5a). Genes with major non-coding tran-
scripts are expressed at higher levels in the nucleus, com-
pared to those with major coding transcripts, while this
trend is inverted in the cytosol (Additional File 1 - Figure
S14). In addition, non-coding major transcripts are less
dominant than coding ones in both compartments (Addi-
tional File 1 - Figure S14): 61% (54.80% to 65.57%, SD =
3.07) of major coding transcripts are also five-fold domi-
nant, while this number goes down to 27% (15.71% to
35.34%, SD = 5.76) for non-coding major ones. Finally, the
annotation revealed that the major non-coding transcripts
correspond to retained introns and processed transcripts,
which lack an open reading frame (see Supp. Methods).
We observe a higher proportion of processed transcripts in
the cytosol and retained introns in the nucleus (Figure 5b).
In order to evaluate the hypothesis that incomplete spli-
cing could explain the higher proportion of major retained
introns in the nucleus, we compared intron expression
levels across cellular compartments (see Methods for
details on the calculation of intron expression). We
observe slightly higher intron expression in the nucleus
compared to the cytosol (Additional File 1 - Figure S15).
We also observe a general trend in the location of major
retained introns towards the transcriptional 3’-end (Addi-
tional File 1 - Figure S15); moreover this trend is more
accentuated in the cytosol than in the nucleus, where it is
possibly masked by the higher intronic expression levels.
Such 3’ intron retention has been previously linked to
Figure 4 Example of a switch event: MBP (myelin basic protein, ENSG00000197971). Read coverage for the gene in brain and kidney.
Further tissues, as well as transcript annotation information, can be visualised in Additional File 1 - Figure S12.
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nonsense-mediated decay (see Discussion). Alternatively,
the prevalence of retained introns as a major transcript
could point to a functional mechanism. We observe that
genes with retained introns as the major transcript both in
nucleus and cytosol are expressed at lower levels in the
later (Additional File 1 - Figure S15), which would be con-
sistent with a regulatory role for retained introns (see Dis-
cussion). We also detect that those genes are associated to
transit peptides and ribosomal components, which is con-
sistent with previous findings indicating that introns regu-
late the expression of ribosomal proteins in yeast
(Additional File 2 - Table S14, see Discussion). On the
other hand, the term ‘processed transcript’ constitutes an
ambiguous category. Manual inspection of a subset of pro-
cessed transcripts that were consistently identified across
all samples as the major transcript suggests that potentially
they could be re-annotated to protein coding, nonsense
mediated decay (NMD) or retained intron (Additional File
2 - Table S15). Together, this seems to suggest that the
true proportion of non-coding major transcripts for pro-
tein coding genes may be lower than the current annota-
tion suggests, and most of these result from retained
introns, which can be explained by incomplete splicing or
potentially have a regulatory role.
Conclusions
In this study we combine RNA-seq data from different pri-
mary tissues, cell lines and cellular compartments to char-
acterise the human protein coding transcriptome from a
functional perspective. We show that in a given condition
most protein coding genes not only express one major
transcript, as recently observed by Djebali et al. [13], but
in most cases the major transcripts are dominating the
transcriptome. This observation is accentuated when
grouping transcripts by TSS, a scenario in which differ-
ences in transcript abundance can be mostly attributed to
splicing. We are aware that transcript quantification from
short read sequences is not a trivial task, and that the cur-
rent annotation is continuously updated to include novel
transcripts. However, our findings are supported by several
quantification methods, including de novo transcript dis-
covery, they are consistent across all datasets, and are reas-
suringly supported by direct evidence from junction reads.
In addition, the single transcript dominance becomes
stronger for highly expressed genes, for which transcript
prediction and quantification have been reported to be
more reliable (RNA-seq Genome Annotation Assessment
Project - RGASP, J Harrow, T Steijger, F Kokocinski, JF
Abril, C Howald, A Reymond, A Mortazavi, B Wold, T
Gingeras, R Guigó, et al., in preparation). In the long term,
longer reads and single cell sequencing will shed more
light on the topic.
Changes in alternative splicing across conditions have
been widely reported, with many studies focusing on the
differences across tissues ([7,8,20], Merkin et al. Science
2012, [24]), where splicing is thought to control the inter-
actions of the protein products [25,26]. Here we quantify
changes in the major transcript across conditions by look-
ing at switch events. We detect a significant number of
genes that express several major transcripts across differ-
ent conditions. Relevant examples include the MBP gene,
PSEN1 (presenilin 1) and ILF3 (interleukin enhancer bind-
ing factor 3). However, in many cases the differences are
subtle. This would suggest that alternative splicing might
be more prevalent in dynamic processes such as develop-
ment and differentiation, rather than steady state. On the
Figure 5 Major non-coding transcripts in protein coding genes. (a) Proportion of the mRNA studied represented by different categories of
transcripts. Average proportions were calculated including all the samples from each dataset. Major non-coding transcripts are more abundant in
nucleus, where the proportion of major coding ones also becomes reduced. (b) Transcript biotype categories for the major non-coding transcripts.
Average proportions were calculated including all the samples from each dataset. Processed transcripts are more abundant in the cytosol, while
retained introns represent the major fraction in the nucleus. Other minor categories that represented <1% of the transcripts were also identified,
but are not visible in the plots.
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other hand, dominant transcripts that are recurrent in
many samples are also interesting, given that they can be
used to build a catalogue for the reference transcriptome.
A closer inspection of a set of recurrent major transcripts
revealed cases where they do not contain the longest CDS,
a criteria often used in resources like UniProt to define a
reference transcript [27], thus exposing some of the limita-
tions of the current definitions and pointing to potential
advantages of taking into account functional data. For
instance, the major transcripts detected for the AES gene
and the CD47 gene are ubiquitously expressed and do not
correspond to the current reference.
We were surprised to find that for a non-negligible frac-
tion of protein coding genes the major transcript is non-
coding and can be classified as retained intron or processed
transcript, which lack an open reading frame [28]. How-
ever, we observe higher prevalence of non-coding major
transcripts in the nucleus, specifically retained introns. Evi-
dence exists suggesting that unspliced or incompletely
spliced mRNAs are confined to the nucleus [29,30]; there-
fore we hypothesize that our observation could reflect
incomplete splicing, as suggested by the higher expression
levels of introns in nucleus. We also observe that retained
introns are preferentially located towards the transcrip-
tional end of transcripts, which has been previously linked
to nonsense mediated decay [31], a control mechanism
that leads to the degradation of unspliced transcripts when
they are transported to the cytosol [32,33]. Nevertheless,
several cases of functionally relevant retained introns have
been described, either as a mechanism to target mRNA
molecules (for example, [34,35], produce alternate protein
products [36] or regulate expression levels [37-39]. We
observe that genes with retained introns as the major tran-
script in both nucleus and cytosol are expressed at consid-
erably lower levels in the later, which could point to a
regulatory role. Finally, we also detected that those genes
are associated to ribosomal components, which is consis-
tent with previous findings indicating that introns regulate
the expression of ribosomal proteins in yeast [40]. On the
other hand, we were able to re-annotate some of the recur-
rent processed transcripts to either coding or retained
intron, thus illustrating a potential application of our ana-
lyses. For example, we revisited the annotation for one of
the transcripts from PARK7 (parkinson protein 7) to pro-
tein coding, from RNF40 (ring finger protein 40) to non-
sense mediated decay and from OSBPL2 (oxysterol binding
protein-like 2) to retained intron.
Overall, it is difficult to predict the impact of our
observations at the protein level. There have been several
studies addressing the relationship between protein and
transcript levels, which in general point at a modest, but
not insignificant correlation [17,21,41,42]. Translational
efficiency, mRNA and protein turnover rates are likely to
have an impact on protein levels [21]. On the other hand,
proteomics studies also show that observing a protein is
unlikely unless there are at least a certain number of
RNA molecules per cell [21-23]. This may be partly due
to insufficient sensitivity of the methods used; neverthe-
less this supports the hypothesis that the abundance of
proteins corresponding to minor transcripts is likely to
be lower than the one corresponding to dominant tran-
scripts. We evaluated this hypothesis by overlapping our
set of dominant transcripts with a set of transcripts pre-
dicted to be translated into proteins by entirely indepen-
dent means [43]. We detected a considerably larger
overlap for those transcripts that have a tendency to be
identified as major, compared to minor ones, suggesting
that major transcripts could be preferentially translated.
On the other hand, alternative splicing not only has an
impact on the proteome repertoire [44-46], but also at
the transcriptome level, cooperating in the control of
expression levels [20,32,47] and contributing to spatial
expression patterns through transcript localisation [46].
This brings in other potential roles for minor transcripts.
However, it is also possible that some of those minor
transcripts are simply the result from noisy splicing
[22,45,48].
The discovery of alternative splicing and many different
classes of non-coding RNAs, together with the establish-
ment of RNA-seq, revealed that the number of transcripts
exceeds many times the number of genes in the human
genome. This has been used to argue that alternative spli-
cing possibly explains the low number of genes compared
to what was believed before it was sequenced [45]. Despite
this diversity of transcripts, our findings indicate that most
protein coding genes express one dominant transcript in a
given condition and that most of the mRNA pool from
protein coding loci arises from major transcripts, thus sug-
gesting that those could be the main contributors to the
proteome. In addition, the ratio of the number of
expressed transcripts to genes in primary tissues is on
average 1.12 and many of the dominant transcripts are the
same across different conditions. Overall, these observa-
tions may help proteome analysis by prioritising the candi-
date proteins that are more likely to be present in a given
sample. At the same time, identification of changes in the
major transcript across conditions can lead to relevant
clinical findings (for example, [18]) and may also be used




We based our analyses on the Illumina Body Map (BM)
dataset and a subset of ENCODE cell lines [49] (ArrayEx-
press accession ids: E-MTAB-513 and E-GEOD-26284,
respectively), jointly covering a total of 21 different tissues
and cell lines, as well as different cellular compartments.
Gonzàlez-Porta et al. Genome Biology 2013, 14:R70
http://genomebiology.com/2013/14/7/R70
Page 8 of 11
Raw fastq files were retrieved from the European Nucleo-
tide Archive [50] using the accession numbers indicated in
Additional File 2 - Table S16. In addition to the publicly
available datasets, we simulated two RNA-seq experiments
using the Flux Simulator [16]. Details on the parameters
used in the simulation have also been listed in Additional
File 2 - Table S16.
Fastq files in the BM dataset were filtered before map-
ping by trimming the last five nucleotides of all reads. Raw
data were mapped to the human genome and transcrip-
tome (Ensembl 66; [1]) using TopHat v1.3.3 [51] and Bow-
tie v0.12.7 [52], respectively.
Gene and transcript study sets
Gene and transcript annotations used in the analyses cor-
respond to those in GENCODE v11 [28]. We focused on
protein coding genes and filtered out those for which at
least one of the annotated transcripts was shorter than
300 bp, given that those transcripts would be lost during
the size selection step in the RNA-seq experiment. In
total, our study set comprises 18,450 protein coding genes,
of which 14,902 have more than one transcript annotated.
Counting reads overlapping exonic and intronic regions
Exonic coordinates were retrieved from the annotation
and used to define intronic regions. Formally, our defini-
tion of intron encompasses those regions that are located
inside genic boundaries and are not overlapped by any
exon in any annotated transcript. We then computed the
number of reads overlapping known exons and introns
using dexseq-count (DEXSeq v1.5.5 [53]) and converted
read counts to FPKM values with custom scripts.
Estimation of gene and transcript expression levels
For each gene, expression levels were calculated as the
average FPKMs of all expressed exons. Independently,
transcript abundances were obtained using three different
tools: MISO v0.4.1 [6], Cufflinks v1.3.0 [4] and MMSEQ
v0.10.0 [5]. MISO and Cufflinks take as input alignments
to the genome, while MMSEQ requires mapping to the
transcriptome, thus the need to use two different mapping
strategies (see above). In all three cases we based the esti-
mates on the existing transcript annotation (see above),
cancelling any option for de novo inference, and converted
those to transcript relative abundances when necessary. In
this manuscript we are referring to the results obtained by
MISO and we use a default FPKM threshold of 1 to con-
sider a gene/transcript as expressed. This threshold has
been suggested as the minimum expression required for
protein detection [21-23] and is different from lower
thresholds that have been suggested to address transcript
detectability [54]. In addition, we include higher expres-
sion thresholds in the analyses (5 and 10 FPKM), since
transcript quantification has been reported to be more
reliable for those (RNA-seq Genome Annotation Assess-
ment Project - RGASP, J Harrow, T Steijger, F Kokocinski,
JF Abril, C Howald, A Reymond, A Mortazavi, B Wold,
T Gingeras, R Guigó, et al., in preparation). Finally, we
consider a transcript as detected independently of its
expression level, given that the gene is expressed.
mRNA pool estimates were calculated as introduced by
[54]. Briefly, the fraction of the studied mRNA pool that
can be explained by the expression of major transcripts
can be represented as the ratio of the sum of FPKMs for
major transcripts vs. the sum of FPKMs for all the tran-
scripts in our study set. All transcripts encoded within
protein coding genes were taken into account in the cal-
culation, independently of their transcript biotype, and
thus we refer to mRNA pool from protein coding loci.
Mitochondrial genes in our study set were discarded for
this analysis (n = 11 in our study set), since they are pre-
sent multiple times in the cell and could bias the quanti-
fication (for example, we found that six transcripts
arising from mitochondrial genes explain almost 50% of
the studied mRNA pool).
Direct evidence from junction reads
Starting with our gene study set (see above), we focused
on those genes for which all of the annotated transcripts
can be uniquely identified by at least one splice junction
(n = 2,306). We then proceeded to identify major tran-
scripts based on coverage evidence (that is, quantifying the
number of reads supporting each junction and taking the
average in case of several splice junctions). For each sam-
ple we calculated the overlap with MISO (Additional
File 2 - Table S8).
De novo transcript discovery using Cufflinks
We used Cufflinks v1.3.0 [4] to discover novel transcripts
in each tissue from the BM dataset and merged all the
obtained annotations using cuffmerge. We then focused
on the subset of transcripts that overlap with known pro-
tein coding genes and filtered out those genes with tran-
scripts shorter than 300 bp, as mentioned previously (see
Gene and transcript study sets). A summary on the num-
ber of genes and transcripts identified can be found in
Additional File 2 - Table S10.
GO analysis
GO analyses were performed with the DAVID software
[55,56]. The reference population was defined by our gene
study set (see above) and an adjusted P value of 0.05 (Ben-
jamini and Hochberg correction [57]) was used as a
threshold for the identification of significant GO terms.
Switch events
We performed a pairwise comparison of the samples in
each dataset and focused on those cases where we detect
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different major coding transcripts. Given a gene G, a pair
of transcripts Ik and Il and a pair of samples Si and Sj, we
say that gene G undergoes an x-fold switch between tran-
scripts Ik and Il in samples Si and Sj, if G is expressed in Si
and Sj and the ratio of the expression of Ii to the expres-
sion of Ij is at least x in Si and no more than 1/x in Sj.
Additionally, we looked at x-fold switch events that are
not accompanied by strong change in the overall gene
expression, to filter out the cases where the change is lar-
gely due to the overall expression change. A switch event
was considered to be expression dependent if the differ-
ence in the expression level of gene G between sample Si
and Sj was bigger than the mean, and expression inde-
pendent otherwise. Finally, we say that there is a strong
switch if the expression of Ik in Si and Il in Sj is at least 5
FPKM, while Ik in Sj and Il in Si less than 1. The intuition
behind the definition of strong switch is that we want to
maximise the chances of obtaining a protein in the first
sample and not in the second, and vice versa, and several
proteomics studies show that observing a protein is unli-
kely unless there are at least a certain number of RNA
molecules per cell [21-23]. Finally, given a sample S and a
switch (Ik, Il) we can calculate ratio r = expression(Ik)/
expression(Il) and its logarithm lr = log(r). Given a switch
(Ik, Il) and set of samples S1, ..., Sj, the vector (lr1, ..., lrj) of
these values is called the expression profile of the switch.
Variability in splicing across tissues
Variability in splicing relative abundances across tissues
was measured using the method introduced by [58].
Additional material
Additional file 1: Supplementary Figures
Additional file 2: Supplementary Tables
Additional file 3: Supplementary Files
Additional file 4: Supplementary Methods and Results
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